Skip to main content
SpringerLink
Log in

The launch of new therapies and increased uptake of current agents will bolster the neuropathic pain market

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources.Launch of New Drugs and Increased Uptake of Current Agents Will Drive Robust Annual 5.2 Percent Growth in the Neuropathic Pain Market. Media Release: 7 Oct 2008. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The launch of new therapies and increased uptake of current agents will bolster the neuropathic pain market. Pharmacoecon. Outcomes News 564, 10 (2008). https://doi.org/10.2165/00151234-200805640-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805640-00027

Keywords

Search

Navigation